Roman physicians recognized as early as 200 AD that women often have benign tumors in the walls of their uterus. Today, experts estimate that by age 50, some 70 percent of white women and more ...

The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

It may sound too good to be true, but Mirena works by slowly releasing progestin, a synthetic form of the hormone progesterone, into your uterus. The progestin thickens your vaginal mucous ...